Savara Inc — Director's Dealing 2021

May 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Savara Inc (SVRA)
CIK: 0001160308
Period of Report: 2021-05-15

Reporting Person: Chowdhury Badrul A. (CHIEF MEDICAL OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-15	Common Stock	M	200000	$0.00	Acquired	200000	Direct
2021-05-17	Common Stock	S	50000	$1.5574	Disposed	150000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-15	Restricted Stock Units	$0.00	M	200000	Disposed		Common Stock (200000)	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2020 in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 15, 2021.

F2: The price is a weighted average sale price. The sale prices ranged from $1.50 to $1.61. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F3: The restricted stock units vested in full on May 15, 2021.